Interferon-beta (IFN-β) activators are a class of compounds or molecules that modulate the production, secretion, or activity of interferon-beta (IFN-β), which is a member of the interferon family of proteins. Interferons, as a group, are proteins naturally produced by cells in response to various stimuli, notably viral infections, and play a crucial role in the innate immune system's defense mechanisms. IFN-β activators can either be endogenous or exogenous in origin. The endogenous activators typically include viral or microbial components that trigger cellular pathways leading to IFN-β production, while exogenous activators can be synthetic compounds or biologics designed to target specific molecular pathways involved in IFN-β regulation.
At the molecular level, the pathway to IFN-β activation typically involves the recognition of pathogen-associated molecular patterns (PAMPs) by host pattern recognition receptors (PRRs). These receptors, which include Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), and cytosolic DNA sensors, initiate signaling cascades upon binding to their specific ligands. This subsequently leads to the activation of various transcription factors like IRF3 and NF-kB. Once activated, these transcription factors translocate to the nucleus, where they drive the expression of IFN-β genes. Furthermore, IFN-β activators can also affect post-transcriptional and post-translational modifications, impacting the stability, localization, or functionality of the IFN-β protein. Overall, understanding the precise mechanisms and pathways by which IFN-β activators operate is vital for a comprehensive grasp of innate immunity and related physiological responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly(I:C) is a synthetic analog of double-stranded RNA. It's recognized by cellular sensors like TLR3, leading to the activation of pathways that culminate in the production of IFN-β and other cytokines. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is a toll-like receptor 7 (TLR7) agonist. By activating TLR7, it can induce a cascade of signaling events that eventually results in the production of IFN-β. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
Resiquimod is also a TLR7 agonist. Similar to imiquimod, it can induce IFN-β production through TLR7-mediated signaling pathways. | ||||||
Loxoribine | 121288-39-9 | sc-203118 sc-203118A | 25 mg 100 mg | $124.00 $390.00 | 1 | |
Loxoribine is a guanosine analog that can activate TLR7. This leads to signaling events that culminate in IFN-β production. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
Gardiquimod is a TLR7 agonist. Like other TLR7 agonists, it induces IFN-β production through activation of TLR7-mediated signaling. | ||||||
Bropirimine | 56741-95-8 | sc-362719 sc-362719A | 10 mg 50 mg | $52.00 $183.00 | ||
Bropirimine is a synthetic immune response modifier that can activate TLR7, which in turn can lead to IFN-β production. | ||||||
CL097 | 1026249-18-2 | sc-507394 | 5 mg | $135.00 | ||
CL097 is another thiazoloquinolone that can activate TLR7 and TLR8. It can lead to IFN-β production upon receptor interaction. | ||||||